Literature DB >> 9425500

Screening for osteopenia and osteoporosis: do the accepted normal ranges lead to overdiagnosis?

A I Ahmed1, G M Blake, J M Rymer, I Fogelman.   

Abstract

Osteoporosis is a common disease which causes significant morbidity and mortality and in many cases may be preventable. In the absence of fragility fractures the accepted method of identifying those at high risk is based upon bone mineral density (BMD) measurements with defined cut-off points. To correctly delineate normal from abnormal, reliable reference ranges appropriate to the observed population are required. We have studied the age-dependent changes in mean BMD and standard deviation at the lumbar spine and femoral neck in a normal population extracted from 4280 women screened for osteopenia and compared our findings with the manufacturer's normal range (MNR). The recent World Health Organization criteria for the diagnosis of osteopenia and osteoporosis using the 'manufacturer's young normal' (MYN) values and our 'study young normal' (SYN) values have been applied. The study normal population (SNP) included 2068 women (mixed social class; mean age 53 years, range 30-79 years). The distribution of mean lumbar spine BMD with age in SNP was generally similar to the MNR. In contrast mean femoral neck bone density from SNP was significantly different from the MNR, ranging from 3% to 12% lower in each 5-year group analysed (p < 0.05). Comparison of standard deviations in spine BMD in SNP against the fixed MNR standard deviation showed a statistically significant increase commencing at 45 years of age. The magnitude of this increase appeared to rise with age and remained significant in the 75- to 79-year age group (p < 0.05). In contrast, standard deviation in femoral neck BMD in SNP appeared relatively constant with age except in the group of women at and around the time of the menopause. The SYN value for mean lumbar spine BMD was 0.994 g/cm2 (cf. MYN value 1.047, p < 0.0001) with a standard deviation of 0.122 g/cm2 (cf. MYN 0.11, p = 0.0005). Similarly our SYN value for femoral neck BMD was 0.787 (cf. MYN value 0.895, p < 0.0001) with a standard deviation of 0.109 (cf. MYN value 0.10, p = 0.0027). Using SYN values 36% (748) for the spine and 33% (675) for the hip of our normal population are classified as osteopenic or osteoporotic. Using MYN values increases the proportion of women classified as osteopenic or osteoporotic to 52% (1078) for the spine and 68% (1409) for the femur. If both sites of measurement are considered simultaneously SYN classifies 46% (952) as either osteopenic or osteoporotic at one or other site, which is increased to 73% (1513) when the MYN values are used. We observe that manufacturer's reference ranges may not be appropriate for the local population and may lead to an erroneously high diagnosis of osteopenia and osteoporosis, which would lead to unnecessary patient anxiety and perhaps errors regarding treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9425500     DOI: 10.1007/s001980050029

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  13 in total

1.  Screening for osteoporosis. No point until we have resolved issues about long term treatment.

Authors:  I Fogelman
Journal:  BMJ       Date:  1999-10-30

2.  Variations in diagnostic performances of dual-energy X-ray absorptiometry in the northwest of The Netherlands.

Authors:  Klaas P Staal; Jan C Roos; Radu A Manoliu; Piet J Kostense; Paul Lips
Journal:  Osteoporos Int       Date:  2003-11-20       Impact factor: 4.507

3.  Bone mineral density of the spine and femur in healthy Saudis.

Authors:  M Salleh M Ardawi; Abdulraouf A Maimany; Talal M Bahksh; Hasan A N Nasrat; Waleed A Milaat; Raja M Al-Raddadi
Journal:  Osteoporos Int       Date:  2004-05-27       Impact factor: 4.507

4.  The fracture risk index and bone mineral density as predictors of vertebral structural failure.

Authors:  Yunbo Duan; François Duboeuf; Françoise Munoz; Pierre D Delmas; Ego Seeman
Journal:  Osteoporos Int       Date:  2005-07-14       Impact factor: 4.507

5.  Establishment of BMD reference plots and determination of peak BMD at multiple skeletal regions in mainland Chinese women and the diagnosis of osteoporosis.

Authors:  Xian-Ping Wu; Er-Yuan Liao; Hong Zhang; Peng-Fei Shan; Xing-Zhi Cao; Shi-Ping Liu
Journal:  Osteoporos Int       Date:  2003-11-04       Impact factor: 4.507

6.  Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium.

Authors:  S Boonen; J-M Kaufman; J-Y Reginster; J-P Devogelaer
Journal:  Osteoporos Int       Date:  2003-01-17       Impact factor: 4.507

7.  Forearm bone mineral density in an unselected population of 2,779 men and women--the HUNT Study, Norway.

Authors:  Siri Forsmo; Arnulf Langhammer; Lisa Forsen; Berit Schei
Journal:  Osteoporos Int       Date:  2004-09-22       Impact factor: 4.507

8.  Direct-to-participant feedback and awareness of bone mineral density testing results in a population-based sample of mid-aged Canadians.

Authors:  E Kingwell; J C Prior; P A Ratner; S M Kennedy
Journal:  Osteoporos Int       Date:  2009-06-04       Impact factor: 4.507

9.  Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis.

Authors:  H Forsblad D'Elia; A Larsen; E Waltbrand; G Kvist; D Mellström; T Saxne; C Ohlsson; E Nordborg; H Carlsten
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

10.  Population-based reference values for bone mineral density in young men.

Authors:  M Høiberg; T L Nielsen; K Wraae; B Abrahamsen; C Hagen; M Andersen; K Brixen
Journal:  Osteoporos Int       Date:  2007-05-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.